Back
ProQR Therapeutics NV Vs. argenx SE Industry Stock Comparison
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
1.74
Seasonality Move:
-2.94%
Buy
57
ARGX
argenx SE
Last Price:
537.51
Seasonality Move:
29.78%
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.79. The Score for PRQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
argenx SE (ARGX)
is a Buy
Is argenx SE a Buy, Sell or Hold?
- The current argenx SE [ARGX] share price is $536.47. The Score for ARGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- ARGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 34.88 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.83 - 2.09) | Sell |
| Bollinger Bands (100): | (1.74 - 2.02) | Sell |
ARGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.31 | Buy |
| Relative Strength Index (14 RSI): | 56.86 | Buy |
| Chaikin Money Flow: | 74140 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (517.66 - 538.84) | Buy |
| Bollinger Bands (100): | (386.41 - 516.69) | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.83 | Sell |
| 20-day SMA: | 1.92 | Sell |
| 50-day SMA: | 1.92 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 1.83 | Sell |
| 20-day EMA: | 1.89 | Sell |
| 50-day EMA: | 1.91 | Sell |
| 200-day EMA: | 1.91 | Sell |
ARGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 533.99 | Buy |
| 20-day SMA: | 529.14 | Buy |
| 50-day SMA: | 510.17 | Buy |
| 200-day SMA: | 422.17 | Buy |
| 8-day EMA: | 533.31 | Buy |
| 20-day EMA: | 529.18 | Buy |
| 50-day EMA: | 505.49 | Buy |
| 200-day EMA: | 447.9 | Buy |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
argenx SE Earnings Growth & ARGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.55 per share, an increase next quarter of $1.83 per share, an increase this year of $5.09 per share, and an increase next year of $6.44 per share.
ProQR Therapeutics NV Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
argenx SE Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||